HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Business (Wellness)

Set Alert for Business {Wellness}

Deals

Set Alert for Deals {Wellness}

Latest From Wellness & Deals

With Timetable In Hand And Icahn On Board, Bausch Health Looks To ‘Expedite Spin-Off’

Executives say Bausch + Lomb spin-out preparations will be completed by the end of Q3. When asked, they elaborated on Carl Icahn’s acquisition of 27.8m shares, for a 7.8% stake, and expansion of the firm’s board by two seats for Icahn’s representatives.

Sales & Earnings M & A

Bausch Shines Planned Spin-Out, Launches First US Preservative-Free OTC Antihistamine Eye Drops

Bausch + Lomb’s Alaway Preservative-Free antihistamine eye drops launch in US, The Bausch Health Companies division planned as spin-out also recently gained South Korean approval for its Lumify OTC redness reliever drops and has submissions under review in other countries.

OTC Drugs Launches

‘Uniquely Positioned’ In Probiotics, IFF Emphasizes Ingredients For Women's, Cognitive, Skin Health

Jennifer Montgomery, IFF’s probiotics marketing manager for the Americas, responds to HBW Insight questions about the firm’s plans to deliver probiotics ingredients and technologies following the recent closing of its acquisition of DuPont Nutrition & Biosciences through a merger agreement.

Dietary Supplements Research & Development
See All

Strategy

Set Alert for Business Strategy {Wellness}

Latest From Wellness & Business Strategies

RB Doubles R&D Spend In Search Of 'Game Changing’ OTC Innovation

With Reckitt's OTC sales falling 3% in 2020, the firm has committed to doubling its R&D spend in search of breakthrough product innovations.

Research & Development Innovation

With Timetable In Hand And Icahn On Board, Bausch Health Looks To ‘Expedite Spin-Off’

Executives say Bausch + Lomb spin-out preparations will be completed by the end of Q3. When asked, they elaborated on Carl Icahn’s acquisition of 27.8m shares, for a 7.8% stake, and expansion of the firm’s board by two seats for Icahn’s representatives.

Sales & Earnings M & A

IFF Plus DuPont N&B Equals $11.2Bn Revenues

"Now it's up to us to look where can we accelerate our portfolio, in which areas and where can we grow the most and deliver good value for our customers,” says CEO Andreas Fibig.

Dietary Supplements M & A
See All

Sales & Earnings

Set Alert for Sales & Earnings {Wellness}

Latest From Wellness & Sales & Earnings

With Timetable In Hand And Icahn On Board, Bausch Health Looks To ‘Expedite Spin-Off’

Executives say Bausch + Lomb spin-out preparations will be completed by the end of Q3. When asked, they elaborated on Carl Icahn’s acquisition of 27.8m shares, for a 7.8% stake, and expansion of the firm’s board by two seats for Icahn’s representatives.

Sales & Earnings M & A

Italy’s OTC Market Records Worst Performance In 15 Years

Italy's non-prescription drug market was hit hard by the effects of COVID-19 in 2020, with volume sales down almost 9% on the previous year.

Italy OTC Drugs

China Q4 Sales Slip But Herbalife Has Record Year

Herbalife Q4 net sales up 15.6% to $1.4bn, a company record for the period, and full-year net sales increased 13.6% as its Asia Pacific, Europe-Middle East-Africa and North America regions reached annual net sales records. USANA reports 5.4% Q4 sales growth in China as full-year sales grew 7% to $1.135bn.

Dietary Supplements Sales & Earnings
See All

Litigation

Set Alert for Legal Issues

Latest From Wellness & Legal Issues

‘Clinically Proven’ Claim Leaving RB's Brain Health Supplements In US Class Action Settlement

Settlement in Southern District of Florida federal court includes a consolidated class action complaint against UK firm’s US businesses comprising cases in Florida, New York and California – filed in 2020 over statements the products were “clinically proven” to improve “brain performance” including focus, memory, learning, accuracy, concentration and reasoning.

Dietary Supplements Legal Issues

California’s Prop 65 Short-Form Warning Changes Are Costly, Confusing And Quick – Lawyer

California’s proposal to amend ‘Clear and Reasonable’ safe harbor warnings will be costly for companies and confusing to consumers, and the one-year phase-in for changes to Prop 65 warnings is “unrealistic,” says consumer product and environmental regulation lawyer Dennis Raglin.

Dietary Supplements State News

US Consumer Health 2020 News: ’60 Minutes’ Probiotic Dip Tops Switches, Monograph, Pandemic

Supplement industry’s bullseye on “60 Minutes” after its June segment critical of probiotic health benefits generated the most reads for a US consumer health and overall for HBW Insight articles in 2020. Articles about COVID-19 enforcement actions weren’t as widely read as coverage of FDA’s reorganization in its OTC drug offices and its approvals of additional ingredients to be available OTC.

Outlook 2020 OTC Drugs
See All
UsernamePublicRestriction

Register